Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
Lisa Weidner, Simon Gänsdorfer, Stephan Unterweger, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104540-104540
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

COVID-19 Antibody Tests and Their Limitations
Guoqiang Liu, James F. Rusling
ACS Sensors (2021) Vol. 6, Iss. 3, pp. 593-612
Closed Access | Times Cited: 199
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel, Evan M. Bloch, William Clarke, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 191
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
Andrea Padoan, Francesco Bonfante, Matteo Pagliari, et al.
EBioMedicine (2020) Vol. 62, pp. 103101-103101
Open Access | Times Cited: 143
Advances in Biosensors and Diagnostic Technologies Using Nanostructures and Nanomaterials
E. Celeste Welch, Jessica M. Powell, Tobias B. Clevinger, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 44
Closed Access | Times Cited: 128
COVID-19 convalescent plasma composition and immunological effects in severe patients
Yeny Acosta‐Ampudia, Diana M. Monsalve, Manuel Rojas, et al.
Journal of Autoimmunity (2021) Vol. 118, pp. 102598-102598
Open Access | Times Cited: 113
Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity
Ramona Dolscheid‐Pommerich, Eva Bartok, Marcel Renn, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 388-392
Open Access | Times Cited: 112
A comparative review of immunoassays for COVID-19 detection
Elham Mohit, Zahra Rostami, Hossein Vahidi
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 6, pp. 573-599
Open Access | Times Cited: 96
Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects
Yousef Rasmi, Xiaokang Li, Johra Khan, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 16, pp. 4137-4159
Open Access | Times Cited: 93
Insights into household transmission of SARS-CoV-2 from a population-based serological survey
Qifang Bi, Justin Lessler, Isabella Eckerle, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 90
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic
Isabel Bergeri, Hannah C. Lewis, Lorenzo Subissi, et al.
Influenza and Other Respiratory Viruses (2021) Vol. 16, Iss. 1, pp. 7-13
Open Access | Times Cited: 76
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander Egger, Wolfgang Prokop, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 8, pp. 1453-1462
Open Access | Times Cited: 65
Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
Kiwook Jung, Sue Shin, Minjeong Nam, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 65
One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
Jie Zhang, Hao Lin, Beiwei Ye, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1072-e1081
Open Access | Times Cited: 62
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
Raquel Rubio‐Acero, Noemi Castelletti, Volker Fingerle, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 3, pp. 1505-1518
Open Access | Times Cited: 60
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 25-34
Open Access | Times Cited: 57
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
Chandima Jeewandara, Achala Kamaladasa, Pradeep Darshana Pushpakumara, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking
Matthew Sims, Gabriel N. Maine, Karen Lins Childers, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. Supplement_2, pp. S154-S162
Open Access | Times Cited: 68
A high-throughput multiplexed microfluidic device for COVID-19 serology assays
Roberto Rodriguez‐Moncayo, Diana F. Cedillo‐Alcantar, Pablo E. Guevara‐Pantoja, et al.
Lab on a Chip (2020) Vol. 21, Iss. 1, pp. 93-104
Closed Access | Times Cited: 60
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
Julia Schwaiger, Michael Karbiener, Claudia Aberham, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 12, pp. 1960-1964
Open Access | Times Cited: 59
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
Mary‐Anne Trabaud, Vinca Icard, Marie-Paule Milon, et al.
Journal of Clinical Virology (2020) Vol. 132, pp. 104613-104613
Open Access | Times Cited: 58
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 57
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
Arantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 3, pp. 485-494
Open Access | Times Cited: 42
Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination
Krzysztof Łukaszuk, Jolanta Kiewisz, Karolina Rozanska, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 840-840
Open Access | Times Cited: 41
The effectiveness of inactivated SARS‐CoV‐2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older
Murat Karameşe, Emin Ediz Tütüncü
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 173-177
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top